1.3 USD
+0.03 (+2.36%)
1.3015 USD
+0 (+0.12%)
ChartMill assigns a Buy % Consensus number of 49% to ZYNE. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 1.28. This target is -1.53% below the current price.
ZYNE was analyzed by 9 analysts. The buy percentage consensus is at 49. So analysts seem to be rather neutral about ZYNE.
In the previous month the buy percentage consensus was at a similar level.
ZYNE was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-08-16 | Canaccord Genuity | Downgrade | Buy -> Hold |
| 2023-08-15 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2022-06-23 | Canaccord Genuity | Maintains | Buy |
ZYNERBA PHARMACEUTICALS INC / ZYNE FAQ
What is the price target for ZYNE stock?
9 analysts have analysed ZYNE and the average price target is 1.28 USD. This implies a price decrease of -1.53% is expected in the next year compared to the current price of 1.3.
How do analysts rate ZYNERBA PHARMACEUTICALS INC (ZYNE)?
The consensus rating for ZYNERBA PHARMACEUTICALS INC (ZYNE) is 48.8889 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
What is the number of analysts for ZYNE stock?
The number of analysts covering ZYNERBA PHARMACEUTICALS INC (ZYNE) is 9.